학술논문

Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies
Document Type
Journal
Source
INFECTIOUS DISEASES AND THERAPY; DEC 16 2023, 22p.
Subject
Language
English
ISSN
21936382